Oxymorphone Hydrochloride is Used for managing moderate to severe pain. It was first introduced by Endo Pharmaceuticals Inc in its drug Numorphan on Approved Prior to Jan 1, 1982. Other drugs containing Oxymorphone Hydrochloride are Opana Er, Opana. 13 different companies have introduced drugs containing Oxymorphone Hydrochloride.

Oxymorphone Hydrochloride Patents

Given below is the list of patents protecting Oxymorphone Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.

Download patent list as spreadsheet

Get the complete list right in your inbox!

Drug Used in	Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Drug Owner
Opana Er	US8871779	Process for preparing morphinan-6-one products with low levels of α,β-unsaturated ketone compounds	Nov 22, 2029	Endo Operations
Opana Er	US8871779	Process for preparing morphinan-6-one products with low levels of α,β-unsaturated ketone compounds	Nov 22, 2029	Endo Pharms
Opana Er	US7851482	Method for making analgesics	Jul 10, 2029	Endo Pharms
Opana Er	US8808737	Method of treating pain utilizing controlled release oxymorphone pharmaceutical compositions and instruction on dosing for renal impairment	Jun 21, 2027	Endo Operations
Opana Er	US8808737	Method of treating pain utilizing controlled release oxymorphone pharmaceutical compositions and instruction on dosing for renal impairment	Jun 21, 2027	Endo Pharms
Opana Er	US8192722	Abuse-proof dosage form	Sep 15, 2025	Endo Pharms
Opana Er	US8114383	Abuse-proofed dosage form	Aug 08, 2024 (Expired)	Endo Pharms
Opana Er	US8075872	Abuse-proofed dosage form	Nov 20, 2023 (Expired)	Endo Pharms
Opana Er	US8309060	Abuse-proofed dosage form	Nov 20, 2023 (Expired)	Endo Pharms
Opana Er	US7276250	Sustained release formulations of oxymorphone	Feb 04, 2023 (Expired)	Endo Operations
Opana Er	US8309112	Coatings for implantable medical devices comprising hydrophilic substances and methods for fabricating the same	Feb 04, 2023 (Expired)	Endo Operations
Opana Er	US8309122	Oxymorphone controlled release formulations	Feb 04, 2023 (Expired)	Endo Pharms
Opana Er	US8329216	Oxymorphone controlled release formulations	Feb 04, 2023 (Expired)	Endo Operations
Opana Er	US8329216	Oxymorphone controlled release formulations	Feb 04, 2023 (Expired)	Endo Pharms
Opana Er	US5662933	Controlled release formulation (albuterol)	Sep 09, 2013 (Expired)	Endo Operations
Opana Er	US5958456	Controlled release formulation (albuterol)	Sep 09, 2013 (Expired)	Endo Operations

Add above patents to watchlist

Oxymorphone Hydrochloride's Family Patents

Full family tree

Oxymorphone Hydrochloride Generic API Manufacturers

Several generic applications have been filed for Oxymorphone Hydrochloride. The first generic version for Oxymorphone Hydrochloride was by Impax Laboratories Inc and was approved on Jun 14, 2010. And the latest generic version is by Ascent Pharmaceuticals Inc and was approved on Feb 2, 2018.

Given below is the list of companies who have filed for Oxymorphone Hydrochloride generic, along with the locations of their manufacturing plants worldwide.